Po-wei Liao
Taitung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Daratumumab, lenalidomide, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma: A real-world propensity score-matched study.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: January 17, 2026
Acalabrutinib Versus Venetoclax Plus Obinutuzumab in Treatment-Naive Chronic Lymphocytic Leukemia: A Real-World Propensity Score-Matched Study.
Journal: Cancer medicine
Published: August 29, 2025
Risk Factors for Febrile Neutropenia in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Undergoing Initial R-CHOP Treatment.
Journal: Clinical Medicine Insights. Oncology
Published: May 19, 2025
The efficacy and tolerability of bortezomib, thalidomide, and dexamethasone induction therapy with a thalidomide dose step-up strategy in patients with newly diagnosed multiple myeloma: A prospective observational study.
Journal: Cancer reports (Hoboken, N.J.)
Published: March 04, 2024
Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: August 29, 2023
Chemotherapy for Metastatic Gastric Cancer: Does Age Matter? A Single-Center, Retrospective, Real-World Study.
Journal: Clinical Medicine Insights. Oncology
Published: April 07, 2022
Venetoclax-induced panniculitis in an acute myeloid leukemia patient.
Journal: Annals of hematology
Published: November 20, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026